Zhiguo Chen

Upregulation of myosin Va by Snail is involved in cancer cell migration and metastasis.

Cancer/testis antigens and clinical risk factors for liver metastasis of colorectal cancer: a predictive panel.

Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors.

Generation of dopaminergic neurons directly from mouse fibroblasts and fibroblast-derived neural progenitors.

Differential roles of TNFR1 and TNFR2 signaling in adult hippocampal neurogenesis.

Autologous transplantation of GDNF-expressing mesenchymal stem cells protects against MPTP-induced damage in cynomolgus monkeys.

MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1.

Introduction to the special topic "stem cells and regenerative medicine".

Lmx1a enhances the effect of iNSCs in a PD model.

Cell therapy for macular degeneration--first phase I/II pluripotent stem cell-based clinical trial shows promise.

Comparison of intracerebral transplantation effects of different stem cells on rodent stroke models.

Cell Therapy for Parkinson's Disease: New Hope from Reprogramming Technologies.

PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype.

Conversion of adult human peripheral blood mononuclear cells into induced neural stem cell by using episomal vectors.

Aberrant trafficking of a Leu89Pro connexin32 mutant associated with X-linked dominant Charcot-Marie-Tooth disease.

Autologous iPSC-derived dopamine neuron transplantation in a nonhuman primate Parkinson's disease model.

Accelerated generation of oligodendrocyte progenitor cells from human induced pluripotent stem cells by forced expression of Sox10 and Olig2.

MRI tracking of autologous pancreatic progenitor-derived insulin-producing cells in monkeys.

SIRT6 deficiency results in developmental retardation in cynomolgus monkeys.

Differentiation of Glial Cells From hiPSCs: Potential Applications in Neurological Diseases and Cell Replacement Therapy.

Ectopic hTERT expression facilitates reprograming of fibroblasts derived from patients with Werner syndrome as a WS cellular model.

Culture of pyramidal neural precursors, neural stem cells, and fibroblasts on various biomaterials.

Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model.

Intravenous Transplantation of Mesenchymal Stem Cells Reduces the Number of Infiltrated Ly6C Cells but Enhances the Proportions Positive for BDNF, TNF-1, and IL-1 in the Infarct Cortices of dMCAO Rats.

Melatonin Treatment Alleviates Spinal Cord Injury-Induced Gut Dysbiosis in Mice.

Employing Endogenous NSCs to Promote Recovery of Spinal Cord Injury.

BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction.

Overcoming BET Inhibitor Resistance in Malignant Peripheral Nerve Sheath Tumors.

Treatment with Humanized Selective CD19CAR-T Cells Shows Efficacy in Highly Treated B-ALL Patients Who Have Relapsed after Receiving Murine-Based CD19CAR-T Therapies.

The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson's Disease Model.

Proteostasis of α-Synuclein and Its Role in the Pathogenesis of Parkinson's Disease.

Mesenchymal Stem/Stromal Cell-Mediated Mitochondrial Transfer and the Therapeutic Potential in Treatment of Neurological Diseases.

Peripheral Circulation and Astrocytes Contribute to the MSC-Mediated Increase in IGF-1 Levels in the Infarct Cortex in a dMCAO Rat Model.

Unusual electrophysiological findings in a Chinese ALS 4 family with SETX-L389S mutation: a three-year follow-up.

Case Report: Humanized Selective CD19CAR-T Treatment Induces MRD-Negative Remission in a Pediatric B-ALL Patient With Primary Resistance to Murine-Based CD19CAR-T Therapy.

Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis.

Astrocytes constitute the major TNF-α-producing cell population in the infarct cortex in dMCAO rats receiving intravenous MSC infusion.

Fecal Microbiota Transplantation Exerts Neuroprotective Effects in a Mouse Spinal Cord Injury Model by Modulating the Microenvironment at the Lesion Site.

Induced neural stem cells from Macaca fascicularis show potential of dopaminergic neuron specification and efficacy in a mouse Parkinson's disease model.

Long-Term Safety and Efficacy of CD19 Humanized Selective CAR-T Therapy in B-ALL Patients Who Have Previously Received Murine-Based CD19 CAR-T Therapy.

Neuroprotective effects of human umbilical cord mesenchymal stromal cells in PD mice via centrally and peripherally suppressing NLRP3 inflammasome-mediated inflammatory responses.

Characterization of Human-Induced Neural Stem Cells and Derivatives following Transplantation into the Central Nervous System of a Nonhuman Primate and Rats.

Probiotic Formulation VSL#3 Interacts with Mesenchymal Stromal Cells To Protect Dopaminergic Neurons via Centrally and Peripherally Suppressing NOD-Like Receptor Protein 3 Inflammasome-Mediated Inflammation in Parkinson's Disease Mice.

GD2 CAR-T cells in combination with Nivolumab exhibit enhanced antitumor efficacy.

MicroRNAs of extracellular vesicles derived from mesenchymal stromal cells alleviate inflammation in dry eye disease by targeting the IRAK1/TAB2/NF-κB pathway.

Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease.

Suppression of TGFβR-Smad3 pathway alleviates the syrinx induced by syringomyelia.

Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK.

Human iPSC-derived endothelial cells promote CNS remyelination via BDNF and mTORC1 pathway.

A C2C3 hinge region enhances the cytotoxicity of anti-CD5 CAR-T cells targeting T cell acute lymphoblastic leukemia.

Human midbrain dopaminergic progenitors.

First-in-human transplantation of autologous induced neural stem cell-derived dopaminergic precursors to treat Parkinson's disease.

Spinal cord injury-induced gut dysbiosis influences neurological recovery partly through short-chain fatty acids.

In vitro differentiation of human CD45 CD34 induced hematopoietic progenitor cells from iPSCs using a monolayer system.

Grafted human-induced pluripotent stem cells-derived oligodendrocyte progenitor cells combined with human umbilical vein endothelial cells contribute to functional recovery following spinal cord injury.

Treatment of Syringomyelia Characterized by Focal Dilatation of the Central Canal Using Mesenchymal Stem Cells and Neural Stem Cells.

Human induced pluripotent stem cell/embryonic stem cell-derived pyramidal neuronal precursors show safety and efficacy in a rat spinal cord injury model.

Immune Cells Promote BDNF Expression by Infiltrated Macrophages via Interleukin 4 in the Cerebral Ischemia of Male Rats.

Modulation of human induced neural stem cell-derived dopaminergic neurons by DREADD reveals therapeutic effects on a mouse model of Parkinson's disease.

The isoflavone puerarin promotes generation of human iPSC-derived pre-oligodendrocytes and enhances endogenous remyelination in rodent models.

Robot-Assisted Stereotactic Microinjection Method for Precision Cell Transplantation in Rat and Canine Models.